The hospital pharmacy leader and the fight against drug diversion

A panel discussion on new tools and guidelines

Join Baker Tilly, Becker’s Hospital Review and other drug diversion specialists for an informative webinar on April 28, 2021 that will discuss drug diversion, pending guidelines for diversion detection and investigations, and best practices for following future guidelines. In addition, the group of panelists will discuss:

  • The potential impact of the upcoming new guidelines for diversion
  • How to build diversion processes
  • Key members and roles of the team
  • The benefits of automation, machine learning, and artificial intelligence to identify diversion


  • Janice Ahlstrom, FHIMSS, CPHIMS, CCSFP, RN, BSN, Director of Risk Advisory Services – Baker Tilly
  • Julia Schimmelpfennig PharmD, MS, BCPS, CDE, Pharmacy Director of St. Elizabeth's Hospital at Hospital Sisters Health System
  • Patrick Yoder, PharmD, Co-founder and Chief Executive Officer at LogicStream Health

Similar events


Single audit readiness: preparing for your post-pandemic federal compliance audit, part 1


One year later: exploring negative oil prices and changes in upstream oil and gas


Cyber Lunch & Learn with Temple University


Financial sustainability for hospitals and health systems in a post-coronavirus environment